we administered a questionnaire to assess maintenance of patients ' blindness at the end of a double-blind clinical trial of osmotic release oral system phenylpropanolamine ( ppa ) vs. placebo in mild obesity .
C0031495
phenylpropanolamine
C0028754
obesity